JPMORGAN CHASE & CO - AQUESTIVE THERAPEUTICS INC ownership

AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 36 filers reported holding AQUESTIVE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.02 and the average weighting 2.8%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of AQUESTIVE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$364
-83.1%
238
-81.8%
0.00%
Q2 2023$2,1581,308
+607.0%
0.00%
Q1 2023$01850.0%0.00%
Q4 2022$0
-100.0%
185
-92.4%
0.00%
Q3 2022$3,000
+200.0%
2,447
+41.4%
0.00%
Q2 2022$1,000
-99.8%
1,731
-99.0%
0.00%
Q1 2022$434,000
-21.7%
166,355
+16.8%
0.00%
Q4 2021$554,000
+7.2%
142,368
+20.2%
0.00%
Q3 2021$517,000
+4.0%
118,465
-5.5%
0.00%
Q2 2021$497,000
+157.5%
125,411
+238.3%
0.00%
Q1 2021$193,000
-7.2%
37,069
-4.6%
0.00%
Q4 2020$208,000
+246.7%
38,863
+187.5%
0.00%
Q3 2020$60,000
+36.4%
13,516
+49.0%
0.00%
Q2 2020$44,000
-95.1%
9,070
-97.8%
0.00%
Q1 2020$907,000
-51.1%
413,962
+29.9%
0.00%
Q4 2019$1,854,000
+420.8%
318,581
+184.9%
0.00%
Q3 2019$356,000
+282.8%
111,803
+391.2%
0.00%
Q2 2019$93,000
+389.5%
22,761
+728.6%
0.00%
Q1 2019$19,000
+137.5%
2,747
+105.8%
0.00%
Q4 2018$8,000
-61.9%
1,335
+10.3%
0.00%
Q3 2018$21,0001,2100.00%
Other shareholders
AQUESTIVE THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Bratton Capital Management, L.P. 9,810,958$16,188,081100.00%
Vahanian & Associates Financial Planning Inc. 725,208$1,196,5933.78%
Bracebridge Capital, LLC 428,571$707,1420.39%
Latash Investments, LLC 243,134$401,1710.32%
XTX Topco Ltd 138,145$227,9390.04%
ARMISTICE CAPITAL, LLC 1,158,000$1,910,7000.03%
OCCUDO QUANTITATIVE STRATEGIES LP 84,355$139,1860.01%
Hillsdale Investment Management Inc. 66,600$109,8900.01%
D.B. Root & Company, LLC 12,950$21,3680.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 147,856$243,9620.01%
View complete list of AQUESTIVE THERAPEUTICS INC shareholders